Literature DB >> 12712440

Clusters of chromosomal imbalances in thymic epithelial tumours are associated with the WHO classification and the staging system according to Masaoka.

Roland Penzel1, Josef Hoegel, Waltraud Schmitz, Hendrik Blaeker, Alicia Morresi-Hauf, Sebastian Aulmann, Erich Hecker, Gunhild Mechtersheimer, Herwart F Otto, Ralf J Rieker.   

Abstract

Using comparative genomic hybridisation, we investigated chromosomal imbalances in 28 cases of thymic epithelial neoplasms including type A, B2, B3, the A component of type AB and different subtypes of type C thymoma. To identify different patterns of chromosomal aberrations associated with the biological behaviour and the histological diversity of thymomas, a hierarchical cluster analysis of 65 cases was performed. The here-reported Comparative Genomic Hybridisation (CGH) data (28 cases) of partly uninvestigated tumour subtypes were pooled with previously published data of chromosomal imbalances of 37 thymomas (Zettl et al. [Am J Pathol 2000;157:257-66]). The analysis of 278 chromosomal subbands yielded 2 main clusters. The first main cluster was characterised by gains of the chromosomal arm 1q, consisted only of type C and B3 thymomas and was further subdivided into 2 subgroups. To the first subgroup only thymomas were attributed, which, in addition to gains of the chromosomal arm 1q, showed losses on 6q and 16q, whereas tumours belonging to the second subgroup exhibited no further recurrent chromosomal alterations. The second main cluster was formed by a heterogeneous group of thymoma types (types A, AB, B2, B3 and C), showing no specific pattern of chromosomal imbalances. In 19 thymomas, no chromosomal imbalances could be detected (3 type B2 and 5 type A thymomas of our study as well as 11 type A thymomas investigated by Zettl et al., Am J Pathol 2000;157:257-66). Chromosomal imbalances were more frequent in type C thymomas than in other subtypes. The distribution of tumour stages according to Masaoka (p = 0.003) and the World Health Organisation (WHO) classification (p < 0.0001) was significantly different in the clusters and subgroups obtained. The groups reflect the staging system and the WHO classification and show that type B3 and type C carcinomas have a strong relationship concerning their chromosomal imbalances. Furthermore, chromosomal imbalances detected in some type A thymomas might be responsible for the aggressive behaviour described in a few cases of this thymoma subtype. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2003        PMID: 12712440     DOI: 10.1002/ijc.11101

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  20 in total

1.  The World Health Organization (WHO) histologic classification of thymomas: a reanalysis.

Authors:  Cesar A Moran; Saul Suster
Journal:  Curr Treat Options Oncol       Date:  2009-02-04

2.  Chromosomal imbalances in carcinoma showing thymus-like elements (CASTLE).

Authors:  Lothar Veits; Gunhild Mechtersheimer; Christina Steger; Jens Freitag; Gregor Mikuz; Kurt W Schmid; Walter Hofmann; Peter Schirmacher; Arndt Hartmann; Ralf J Rieker
Journal:  Virchows Arch       Date:  2011-07-07       Impact factor: 4.064

3.  [Primary metastatic renal metastatic carcinoid tumor in a young male patient: a contribution to the differential diagnosis of neuroendocrine tumors].

Authors:  M L Gross; I Berger
Journal:  Pathologe       Date:  2007-07       Impact factor: 1.011

Review 4.  Thymic malignancies: from clinical management to targeted therapies.

Authors:  Ronan J Kelly; Iacopo Petrini; Arun Rajan; Yisong Wang; Giuseppe Giaccone
Journal:  J Clin Oncol       Date:  2011-11-21       Impact factor: 44.544

5.  Cystic thymoma.

Authors:  Ralf J Rieker; Sebastian Aulmann; Philipp A Schnabel; Falk-Udo Sack; Herwart F Otto; Gunhild Mechtersheimer; Peter Schirmacher; Hendrik Bläker
Journal:  Pathol Oncol Res       Date:  2005-03-31       Impact factor: 3.201

Review 6.  [Thymic carcinomas].

Authors:  P Ströbel; C-A Weis; A Marx
Journal:  Pathologe       Date:  2016-09       Impact factor: 1.011

Review 7.  [Thymomas].

Authors:  A Marx; C-A Weis; P Ströbel
Journal:  Pathologe       Date:  2016-09       Impact factor: 1.011

Review 8.  Treatment of advanced thymoma and thymic carcinoma.

Authors:  Arun Rajan; Giuseppe Giaccone
Journal:  Curr Treat Options Oncol       Date:  2009-04-21

9.  Comprehensive genomic analysis reveals clinically relevant molecular distinctions between thymic carcinomas and thymomas.

Authors:  Nicolas Girard; Ronglai Shen; Tianhua Guo; Maureen F Zakowski; Adriana Heguy; Gregory J Riely; James Huang; Christopher Lau; Alex E Lash; Marc Ladanyi; Agnes Viale; Cristina R Antonescu; William D Travis; Valerie W Rusch; Mark G Kris; William Pao
Journal:  Clin Cancer Res       Date:  2009-10-27       Impact factor: 12.531

Review 10.  Clinical and pathological aspects of thymic epithelial tumors.

Authors:  Meinoshin Okumura; Hiroyuki Shiono; Masato Minami; Masayoshi Inoue; Tomoki Utsumi; Yoshihisa Kadota; Yoshiki Sawa
Journal:  Gen Thorac Cardiovasc Surg       Date:  2008-01-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.